Stock Analiz

Amgen Inc. (AMGN) stock forecast and price target

Price $465.67 · data as of November 13, 2026

12-month price target

Average target$431.81
Upside / downside−7.3%
Analysts29
ConsensusHold
Low $230.00Average $431.81High $536.00

Gold marker: average target · white marker: today’s price ($465.67)

Analyst ratings

Strong buy 4Buy 7Hold 18Sell 3Strong sell 2

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$23.53+7.8%$39.5B
Next fiscal year
ends December 31, 2027
$25.06+6.5%$41.3B
Next quarter
ends December 31, 2026
$5.64+6.7%$10.5B
Quarter after
ends March 31, 2027
$5.72+11.1%$9.5B

Consensus of the analysts covering Amgen, updated daily. In the last 30 days 25 estimates were raised and 2 lowered.

Our model vs. Wall Street

Analysts see 7.3% downside over 12 months. Our discounted cash flow model with moderate assumptions puts Amgen’s intrinsic value about 26% below today’s market value, and it scores 2.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Amgen stock price target?

The average 12-month target from 29 analysts is $431.81, 7.3% below the current price of $465.67 Targets range from $230.00 to $536.00.

Is Amgen a buy according to analysts?

The consensus rating is “Hold” (4 strong buy, 7 buy, 18 hold, 3 sell, 2 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Amgen expected to earn?

Analysts expect EPS of $23.53 for the fiscal year ending December 31, 2026 and $25.06 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.